FDA Inspection 1168399 — Erin McElvania, PhD.
The FDA completed an inspection of Erin McElvania, PhD. on Mar 31, 2022 in Evanston, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 31, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Evanston, IL (United States)
Additional Details
Clinical Investigator (CI)